FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year. Read More

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *